Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the antitumor activity of inotuzumab ozogamicin in subjects with indolent NHL who have relapsed or are refractory to rituximab and chemotherapy, or anti CD-20 radioimmunotherapy (RIT), as measured by the Overall Response Rate (ORR).
Inclusion criteria
- INDOLENT NON-HODGKIN'S LYMPHOMA